KIWA’s New Management Team Started the Restructuring
Ontario, Calif., Nov. 5, 2022 (Globe Newswire) — Kiwa Bio-Tech Products Group Corporation (OTCBB: KWBT). On November 2, 2022, XIAOMAN completed the acquisition of an asset of more than RMB 500 million (approximately 68 million USD), and plans to merge this part of the asset into KIWA after the Company’s Board re-election and audit work…